Article
Diagnostics firm rejects Escalon stock offer
London-The board of Drew Scientific Group PLC, a diagnostics company specializing in the design, manufacture, sale, and distribution of analytical systems for laboratory testing, has rejected Escalon Medical Corp.'s offer to trade its stock for Drew shares.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
